Navigation Links
New Preliminary Data from Two Studies Show Clinical Activity of Neratinib in Combination with Trastuzumab and in Combination with Paclitaxel in Advanced HER-2 Positive Breast Cancer
Date:5/29/2009

h Pharmaceuticals, Wyeth Consumer Healthcare and Fort Dodge Animal Health.

The statements in this press release that are not historical facts are forward-looking statements that are subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. In particular, clinical trial data are subject to differing interpretations, and the views of regulatory agencies, medical and scientific experts and others may differ from ours. There can be no assurance that neratinib will ever receive regulatory approval or be successfully developed and commercialized. Other risks and uncertainties that could cause actual results to differ materially from those expressed or implied by forward-looking statements include, among others, risks related to our proposed merger with Pfizer, including satisfaction of the conditions of the proposed merger on the proposed timeframe or at all, contractual restrictions on the conduct of our business included in the merger agreement, and the potential for loss of key personnel, disruption in key business activities or any impact on our relationships with third parties as a result of the announcement of the proposed merger; the inherent uncertainty of the timing and success of, and expense associated with, research, development, regulatory approval and commercialization of our products and pipeline products; government cost-containment initiatives; restrictions on third-party payments for our products; substantial competition in our industry, including from branded and generic products; emerging data on our products and pipeline products; the importance of strong performance from our principal products and our anticipated new product introductions; the highly regulated nature of our business; product liability, intellectual property and other litigation risks and environmental liabilities; the outcome of government investigations; uncertainty
'/>"/>

SOURCE Wyeth Pharmaceuticals
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. TargeGen Announces Successful Completion of Patient Enrollment in Clinical Trial of JAK2 Inhibitor TG101348 in Myelofibrosis Patients and Scheduled Presentation of Preliminary Trial Data at EHA Conference in Berlin
2. Metabolic Solutions Development Company Announces Preliminary Results from Phase IIa Clinical Trial
3. Peregrine Pharmaceuticals Reports Positive Preliminary Data From Phase II Bavituximab Lung Cancer Trial
4. Ascenta Therapeutics Announces Positive Preliminary Results with AT-101 in Docetaxel Refractory Prostate Cancer
5. Genaera Presents Preliminary Phase 1b Data for Trodusquemine (MSI-1436)
6. Arena Pharmaceuticals Announces Preliminary Results of Phase 2b Clinical Trial of APD125 for the Treatment of Insomnia
7. Neuronetrix Announces Preliminary Alzheimers Study Results at the Society for Neuroscience Conference
8. CuraGen Announces Preliminary Data from Ongoing Phase II Study Showing Clinical Activity of CR011-vcMMAE in Patients with Metastatic Melanoma
9. Preliminary Data From Experimental Study Demonstrate Increased Mortality in Stroke Patients Treated With Epoetin Alfa
10. What is the Optimal Method of Ischemia Evaluation in WomeN: Preliminary Data from the WOMEN Study
11. Pharmasset Reports Preliminary Results of a 4-week Combination Study of R7128 for the Treatment of Chronic Hepatitis C
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2015)... and VANCOUVER, British Columbia ... OGXI ) announced today that it will report ... 14, 2015. Company management will host a conference call ... provide an overview of financial results, clinical development programs ... access the webcast, log on to the Investor Relations ...
(Date:5/4/2015)... 2015 PTC Therapeutics, Inc. (NASDAQ: PTCT ) ... the first quarter ending March 31, 2015. ... our first full quarter since the commercial launch, we have ... for nonsense mutation Duchene Muscular Dystrophy. We now have 82 ... since our last earnings call," stated Stuart W. Peltz ...
(Date:5/4/2015)... BEACH, Va. , May 4, 2015 /PRNewswire/ ... investment company focused on the lower middle market, ... Inc. ("BMS").  Founded in 1969 and based in ... provides a full range of radiation products for ... Fox Three partnered with Peninsula Capital Partners ("Peninsula"), ...
Breaking Medicine Technology:PTC Therapeutics Reports First Quarter 2015 Financial Results and Provides Corporate Update 2PTC Therapeutics Reports First Quarter 2015 Financial Results and Provides Corporate Update 3PTC Therapeutics Reports First Quarter 2015 Financial Results and Provides Corporate Update 4PTC Therapeutics Reports First Quarter 2015 Financial Results and Provides Corporate Update 5PTC Therapeutics Reports First Quarter 2015 Financial Results and Provides Corporate Update 6PTC Therapeutics Reports First Quarter 2015 Financial Results and Provides Corporate Update 7PTC Therapeutics Reports First Quarter 2015 Financial Results and Provides Corporate Update 8PTC Therapeutics Reports First Quarter 2015 Financial Results and Provides Corporate Update 9Fox Three Partners, LLC Acquires Burlington Medical Supplies, Inc. 2
... , Study shows 4% CHG antiseptic is effective against a ... Ga., June 24 Hand washing with a 4% chlorhexidine ... to stop the spread of the H1N1 Swine Flu Virus. ... Personnel Hand Antiseptic Towelettes have been tested and found to ...
... Jude study shows personalized chemotherapy can improve cure rate ... leukemia treatment , , MEMPHIS, Tenn., June ... can be successfully treated using a carefully personalized chemotherapy ... Research Hospital have found. Such radiation of the brain ...
Cached Medicine Technology:Hand Washing with 4% CHG Antiseptic Kills Flu Viruses 2Acute Lymphoblastic Leukemia, the Most Common Childhood Cancer, Is Curable Without Preventive Cranial Radiation 2Acute Lymphoblastic Leukemia, the Most Common Childhood Cancer, Is Curable Without Preventive Cranial Radiation 3Acute Lymphoblastic Leukemia, the Most Common Childhood Cancer, Is Curable Without Preventive Cranial Radiation 4
(Date:5/4/2015)... May 04, 2015 Leonardo J. Lozada, ... chief physician executive, and William C. Daniel, M.D., Saint ... accepted personal invitations from the Secretary of the Air ... (NSF) at the Air War College, Maxwell Air Force ... influential citizens to senior U.S. and international officers and ...
(Date:5/4/2015)... 04, 2015 Milton Hershey School® has ... Alumnus of the Year, recognizing his commitment to pediatric ... he sets for MHS students. , “Dr. Graves is ... when children are provided a top-notch education, a nurturing ... passions,” said Pete Gurt ’85, president of MHS. “He ...
(Date:5/4/2015)... 04, 2015 McNeil & Company ... the expansion of coverage for its Emergency Services ... of industry-tailored insurance and proactive risk management to the ... are dedicated to providing our customers with unparalleled service ... evolving needs. We are excited to launch over 100 ...
(Date:5/4/2015)... LiveSchool ” was featured on NewsWatch as part of ... latest and coolest applications on the market for iOS, ... and technology expert, conducted the app review and shared ... students with good behavior. , Positive re-enforcement is more ... And the good people at LiveSchool have taken note ...
(Date:5/4/2015)... The American Telemedicine Association (ATA) today released ... identify gaps in coverage and reimbursement, and physician practice ... Telemedicine Gaps Reports last September, many state regulating bodies ... impact healthcare delivery in their state,” said Jonathan Linkous, ... across the nation, ATA reevaluated the indicators for each ...
Breaking Medicine News(10 mins):Health News:Saint Luke’s Health System Leadership Selected to Attend National Security Forum 2Health News:Milton Hershey School Names 2015 Alumnus of the Year 2Health News:Insurance Leader McNeil & Company Expands Coverage for Emergency Services Insurance Program (ESIP), Launches Enhancements to Property and Casualty Insurance Package 2Health News:Insurance Leader McNeil & Company Expands Coverage for Emergency Services Insurance Program (ESIP), Launches Enhancements to Property and Casualty Insurance Package 3Health News:An Application for Teachers to Reward Students with Good Behavior Was Featured on NewsWatch Television 2Health News:American Telemedicine Association Delivers New State Report Cards on Telemedicine 2Health News:American Telemedicine Association Delivers New State Report Cards on Telemedicine 3
... Technique allows trapped air a way out, experts ... Airway bypass to treat emphysema patients shows promise, ... obstructive pulmonary disease (COPD), is a progressive, irreversible ... tissue. Treatment options are limited. , The new ...
... to cut down on bleeding during cardiac surgery , , THURSDAY, ... Administration on Thursday said it will review the safety of ... was stopped early due to an increase in deaths for ... approved by the FDA in 1993, is typically used to ...
... testified at the Senate Finance Committee hearing today that,the ... needs of,its self-employed members. Nearly 30 percent of NAR ... - 84 percent of Realtors who do,not have coverage ... tax incentives for the self-employed and for small,employers, coupled ...
... Oct. 25 /PRNewswire-FirstCall/ - SXC Health Solutions Inc.,(NASDAQ: ... Glenn, Chairman and,Chief Executive Officer, will host a conference ... to discuss the Company,s fiscal 2007 third quarter,financial results. ... at 6:00 a.m. ET that same day. All ...
... and EPS; ... Md., Oct. 25 MICROS Systems, Inc.,(Nasdaq: MCRS ), a ... announced the results for its,fiscal 2008 first quarter ended September 30, ... $216.5 million, an increase of $42.8 million, ...
... Income to Common Stockholders Grows 71% During the Second Fiscal ... ... Company Reiterates Fiscal 2008 Guidance, MOUNTAIN VIEW, ... software and,strategic services designed to optimize clinical drug development, today,announced financial results for ...
Cached Medicine News:Health News:FDA to Review Clotting Drug After Trial Suggests Death Risk 2Health News:FDA to Review Clotting Drug After Trial Suggests Death Risk 3Health News:FDA to Review Clotting Drug After Trial Suggests Death Risk 4Health News:Nearly 30 Percent of Realtors(R) Lack Health Insurance 2Health News:SXC Health Solutions to Host Fiscal 2007 Third Quarter Financial Results Conference Call 2Health News:MICROS Reports Fiscal 2008 First Quarter Results 2Health News:MICROS Reports Fiscal 2008 First Quarter Results 3Health News:MICROS Reports Fiscal 2008 First Quarter Results 4Health News:MICROS Reports Fiscal 2008 First Quarter Results 5Health News:MICROS Reports Fiscal 2008 First Quarter Results 6Health News:MICROS Reports Fiscal 2008 First Quarter Results 7Health News:Pharsight Achieves $7.3 Million in Quarterly Revenue 2Health News:Pharsight Achieves $7.3 Million in Quarterly Revenue 3Health News:Pharsight Achieves $7.3 Million in Quarterly Revenue 4Health News:Pharsight Achieves $7.3 Million in Quarterly Revenue 5Health News:Pharsight Achieves $7.3 Million in Quarterly Revenue 6Health News:Pharsight Achieves $7.3 Million in Quarterly Revenue 7Health News:Pharsight Achieves $7.3 Million in Quarterly Revenue 8Health News:Pharsight Achieves $7.3 Million in Quarterly Revenue 9Health News:Pharsight Achieves $7.3 Million in Quarterly Revenue 10Health News:Pharsight Achieves $7.3 Million in Quarterly Revenue 11Health News:Pharsight Achieves $7.3 Million in Quarterly Revenue 12
Fahlbusch hypophysectomie instrument, spoon, bayonet-shaped, malleable....
... is pouncing on the T.L.I.F. market as the ... of CFRP clinical history and the amazing success ... Leopard is sure to be king of the ... from 7-18 mm in height. The footprint is ...
... Cage System provides anterior column support for ... from T1 to L5. The system consists ... Polymer cages that are stacked to a ... Peek Carbon Fiber Reinforced Polymer material emulates ...
... Jaguar Lumbar I/F Cage system is a ... separate the mechanical and biologic functions of ... Lumbar I/F Cage provides a device designed ... and uses autologous cancellous bone, the best ...
Medicine Products: